Kühn, T., Floegel, A., Sookthai, D., Johnson, T., Rolle-Kampczyk, U., Otto, W., . . . Kaaks, R. (2016). Higher plasma levels of lysophosphatidylcholine 18: 0 are related to a lower risk of common cancers in a prospective metabolomics study. BMC Med.
Citação norma ChicagoKühn, Tilman, Anna Floegel, Disorn Sookthai, Theron Johnson, Ulrike Rolle-Kampczyk, Wolfgang Otto, Martin von Bergen, Heiner Boeing, and Rudolf Kaaks. "Higher Plasma Levels of Lysophosphatidylcholine 18: 0 Are Related to a Lower Risk of Common Cancers in a Prospective Metabolomics Study." BMC Med 2016.
MLA引文Kühn, Tilman, et al. "Higher Plasma Levels of Lysophosphatidylcholine 18: 0 Are Related to a Lower Risk of Common Cancers in a Prospective Metabolomics Study." BMC Med 2016.